Ligand Pharma's total assets for Q2 2025 were $948.60M, an increase of 4.77% from the previous quarter. LGND total liabilities were $120.08M for the fiscal quarter, a 9.26% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.